Identification of an aggressive prostate cancer predisposing variant at 11q13

International Journal of Cancer

Volumn 129, Issue 3, 2011, Pages 599-606

  Nurminen, Riikka ^a   Wahlfors, Tiina ^a   Tammela, Teuvo L J ^b   Schleutker, Johanna ^a  

^a TAMPERE UNIVERSITY OF TECHNOLOGY   (Finland)

^b TAMPERE UNIVERSITY HOSPITAL   (Finland)

Author keywords

11q13; aggressiveness; association; EMSY; prostate cancer genetics

Indexed keywords

GENOMIC DNA; NUCLEAR PROTEIN; PROSTATE SPECIFIC ANTIGEN; PROTEIN EMSY; UNCLASSIFIED DRUG;

ADULT; AGED; AMINO ACID SEQUENCE; ARTICLE; CANCER GROWTH; CANCER RISK; CHROMOSOME 11Q; CONTROLLED STUDY; EMSY GENE; FAMILIAL CANCER; FINLAND; GENE FREQUENCY; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC MARKER; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GLEASON SCORE; HIGH RESOLUTION MELTING ANALYSIS; HISTOPATHOLOGY; HUMAN; INTRON; MAJOR CLINICAL STUDY; MALE; PENETRANCE; POPULATION BASED CASE CONTROL STUDY; PRIORITY JOURNAL; PROSTATE CANCER; SINGLE NUCLEOTIDE POLYMORPHISM; TUMOR GENE;

ADULT; AGED; AGED, 80 AND OVER; CASE-CONTROL STUDIES; CHROMOSOME MAPPING; CHROMOSOMES, HUMAN, PAIR 11; DISEASE PROGRESSION; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENETIC VARIATION; HUMANS; MALE; MIDDLE AGED; NEOPLASM PROTEINS; NUCLEAR PROTEINS; PROSTATIC NEOPLASMS; REPRESSOR PROTEINS;

EID: 79958021225     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.25754     Document Type: Article

References (44)

1. Finnish cancer registry, Available at:, Accessed July 6, 2009.
2. Ostrander EA, Markianos K, Stanford JL,. Finding prostate cancer susceptibility genes. Annu Rev Genomics Hum Genet 2004; 5: 151-75. (Pubitemid 39362744)
3. Carter BS, Bova GS, Beaty TH, Steinberg GD, Childs B, Isaacs WB, Walsh PC,. Hereditary prostate cancer: epidemiologic and clinical features. J Urol 1993; 150: 797-802. (Pubitemid 23241269)
4. Lichtenstein P, Holm NV, Verkasalo PK, Iliadou A, Kaprio J, Koskenvuo M, Pukkala E, Skytthe A, Hemminki K,. Environmental and heritable factors in the causation of cancer-analyses of cohorts of twins from Sweden, Denmark, and Finland. N Engl J Med 2000; 343: 78-85. (Pubitemid 30451850)
5. Carter BS, Beaty TH, Steinberg GD, Childs B, Walsh PC,. Mendelian inheritance of familial prostate cancer. Proc Natl Acad Sci USA 1992; 89: 3367-71.
6. Monroe KR, Yu MC, Kolonel LN, Coetzee GA, Wilkens LR, Ross RK, Henderson BE,. Evidence of an X-linked or recessive genetic component to prostate cancer risk. Nat Med 1995; 1: 827-9.
7. Pakkanen S, Baffoe-Bonnie AB, Matikainen MP, Koivisto PA, Tammela TL, Deshmukh S, Ou L, Bailey-Wilson JE, Schleutker J,. Segregation analysis of 1,546 prostate cancer families in Finland shows recessive inheritance. Hum Genet 2007; 121: 257-67. (Pubitemid 46404459)
8. Schleutker J, Baffoe-Bonnie AB, Gillanders E, Kainu T, Jones MP, Freas-Lutz D, Markey C, Gildea D, Riedesel E, Albertus J, Gibbs KD Jr, Matikainen M, et al,. Genome-wide scan for linkage in Finnish hereditary prostate cancer (HPC) families identifies novel susceptibility loci at 11q14 and 3p25-26. Prostate 2003; 57: 280-9. (Pubitemid 37487073)
9. Eeles RA, Kote-Jarai Z, Giles GG, Olama AA, Guy M, Jugurnauth SK, Mulholland S, Leongamornlert DA, Edwards SM, Morrison J, Field HI, Southey MC, et al,. Multiple newly identified loci associated with prostate cancer susceptibility. Nat Genet 2008; 40: 316-21. (Pubitemid 351311772)
10. Thomas G, Jacobs KB, Yeager M, Kraft P, Wacholder S, Orr N, Yu K, Chatterjee N, Welch R, Hutchinson A, Crenshaw A, Cancel-Tassin G, et al,. Multiple loci identified in a genome-wide association study of prostate cancer. Nat Genet 2008; 40: 310-5. (Pubitemid 351311773)
11. Kote-Jarai Z, Easton DF, Stanford JL, Ostrander EA, Schleutker J, Ingles SA, Schaid D, Thibodeau S, Dörk T, Neal D, Donovan J, Hamdy F, et al,. Multiple novel prostate cancer predisposition loci confirmed by an International study: the PRACTICAL consortium. Cancer Epidemiol Biomarkers Prev 2008; 17: 2052-61.
12. Breyer JP, McReynolds KM, Yaspan BL, Bradley KM, Dupont WD, Smith JR,. Genetic variants and prostate cancer risk: candidate replication and exploration of viral restriction genes. Cancer Epidemiol Biomarkers Prev 2009; 18: 2137-44.
13. Waters KM, Le Marchand L, Kolonel LN, Monroe KR, Stram DO, Henderson BE, Haiman CA,. Generalizability of associations from prostate cancer genome-wide association studies in multiple populations. Cancer Epidemiol Biomarkers Prev 2009; 18: 1285-9.
14. Gudmundsson J, Sulem P, Gudbjartsson DF, Blondal T, Gylfason A, Agnarsson BA, Benediktsdottir KR, Magnusdottir DN, Orlygsdottir G, Jakobsdottir M, Stacey SN, Sigurdsson A, et al,. Genome-wide association and replication studies identify four variants associated with prostate cancer susceptibility. Nat Genet 2009; 41: 1122-6.
15. Zheng SL, Stevens VL, Wiklund F, Isaacs SD, Sun J, Smith S, Pruett K, Wiley KE, Kim ST, Zhu Y, Zhang Z, Hsu FC, et al,. Two independent prostate cancer risk-associated Loci at 11q13. Cancer Epidemiol Biomarkers Prev 2009; 18: 1815-20.
16. Rökman A, Koivisto PA, Matikainen MP, Kuukasjarvi T, Poutiainen M, Helin HJ, Karhu R, Kallioniemi OP, Schleutker J,. Genetic changes in familial prostate cancer by comparative genomic hybridization. Prostate 2001; 46: 233-9. (Pubitemid 32142770)
17. Das K, Lau W, Sivaswaren C, Ph T, Fook-Chong S, Sl T, Cheng C,. Chromosomal changes in prostate cancer: a fluorescence in situ hybridization study. Clin Genet 2005; 68: 40-7. (Pubitemid 40867537)
18. Kasahara K, Taguchi T, Yamasaki I, Kamada M, Shuin T,. Genetic changes in localized prostate cancer of Japanese patients shown by comparative genomic hybridization. Cancer Genet Cytogenet 2005; 159: 84-8. (Pubitemid 40626723)
19. Jiang M, Li M, Fu X, Huang Y, Qian H, Sun R, Mao Y, Xie Y, Li Y,. Simultaneously detection of genomic and expression alterations in prostate cancer using cDNA microarray. Prostate 2008; 68: 1496-509.
20. Xu J, Zheng SL, Isaacs SD, Wiley KE, Wiklund F, Sun J, Kader AK, Li G, Purcell LD, Kim ST, Hsu FC, Stattin P, et al,. Inherited genetic variant predisposes to aggressive but not indolent prostate cancer. Proc Natl Acad Sci USA 2010; 107: 2136-40.
21. Pierconti F, Martini M, Pinto F, Cenci T, Capodimonti S, Calarco A, Bassi PF, Larocca LM,. Epigenetic silencing of SOCS3 identifies a subset of prostate cancer with an aggressive behavior. Prostate, in press.
22. Hughes-Davies L, Huntsman D, Ruas M, Fuks F, Bye J, Chin SF, Milner J, Brown LA, Hsu F, Gilks B, Nielsen T, Schulzer M, et al,. EMSY links the BRCA2 pathway to sporadic breast and ovarian cancer. Cell 2003; 115: 523-35. (Pubitemid 37506042)
23. Brown LA, Irving J, Parker R, Kim H, Press JZ, Longacre TA, Chia S, Magliocco A, Makretsov N, Gilks B, Pollack J, Huntsman D,. Amplification of EMSY, a novel oncogene on 11q13, in high grade ovarian surface epithelial carcinomas. Gynecol Oncol 2006; 100: 264-70. (Pubitemid 43075259)
24. Brown LA, Kalloger SE, Miller MA, Shih I, McKinney SE, Santos JL, Swenerton K, Spellman PT, Gray J, Gilks CB, Huntsman DG,. Amplification of 11q13 in ovarian carcinoma. Genes Chromosomes Cancer 2008; 47: 481-9. (Pubitemid 351657183)
25. Kirkegaard T, Nielsen KV, Jensen LB, Campbell FM, Muller S, Tovey SM, Brown S, Cooke TG, Bartlett JM,. Genetic alterations of CCND1 and EMSY in breast cancers. Histopathology 2008; 52: 698-705. (Pubitemid 351600044)
26. van Hattem WA, Carvalho R, Li A, Offerhaus GJ, Goggins M,. Amplification of EMSY gene in a subset of sporadic pancreatic adenocarcinomas. Int J Clin Exp Pathol 2008; 1: 343-51.
27. Davies AA, Masson JY, McIlwraith MJ, Stasiak AZ, Stasiak A, Venkitaraman AR, West SC,. Role of BRCA2 in control of the RAD51 recombination and DNA repair protein. Mol Cell 2001; 7: 273-82. (Pubitemid 32206495)
28. Milner J, Ponder B, Hughes-Davies L, Seltmann M, Kouzarides T,. Transcriptional activation functions in BRCA2. Nature 1997; 386: 772-3.
29. Garapaty S, Xu CF, Trojer P, Mahajan MA, Neubert TA, Samuels HH,. Identification and characterization of a novel nuclear protein complex involved in nuclear hormone receptor-mediated gene regulation. J Biol Chem 2009; 284: 7542-52.
30. Purcell S, Neale B, Todd-Brown K, Thomas L, Ferreira MAR, Bender D, Maller J, Sklar P, de Bakker PIW, Daly MJ, Sham PC,. PLINK: a toolset for whole-genome association and population-based linkage analysis. Am J Hum Genet 2007; 81: 559-75. (Pubitemid 47330214)
31. R Development Core Team. R: a language and environment for statistical computing, Vienna, Austria: R Foundation for Statistical Computing, 2008.
32. Barrett JC, Fry B, Maller J, Daly MJ,. Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 2005; 21: 263-5. (Pubitemid 40202029)
33. Gabriel SB, Schaffner SF, Nguyen H, Moore JM, Roy J, Blumenstiel B, Higgins J, DeFelice M, Lochner A, Faggart M, Liu-Cordero SN, Rotimi C, et al,. The structure of haplotype blocks in the human genome. Science 2002; 296: 2225-9. (Pubitemid 34680308)
34. Huang HY, Chien CH, Jen KH, Huang HD,. RegRNA: an integrated web server for identifying regulatory RNA motifs and elements. Nucl Acids Res 2006; 34: W429-34.
35. NCBI SNP database, Available at: Accessed on April, 13, 2010.
36. Ostrander EA, Udler MS,. The role of the BRCA2 gene in susceptibility to prostate cancer revisited. Cancer Epidemiol Biomarkers Prev 2008; 17: 1843-8.
37. Ikonen T, Matikainen MP, Syrjäkoski K, Mononen N, Koivisto PA, Rökman A, Seppälä EH, Kallioniemi OP, Tammela TL, Schleutker J,. BRCA1 and BRCA2 mutations have no major role in predisposition to prostate cancer in Finland. J Med Genet 2003; 40: e98.
38. Xu J, Isaacs SD, Sun J, Li G, Wiley KE, Zhu Y, Hsu FC, Wiklund F, Turner AR, Adams TS, Liu W, Trock BJ, et al,. Association of prostate cancer risk variants with clinicopathologic characteristics of the disease. Clin Cancer Res 2008; 14: 5819-24.
39. FitzGerald LM, Kwon EM, Koopmeiners JS, Salinas CA, Stanford JL, Ostrander EA,. Analysis of recently identified prostate cancer susceptibility loci in a population-based study: associations with family history and clinical features. Clin Cancer Res 2009; 15: 3231-7.
40. Kader AK, Sun J, Isaacs SD, Wiley KE, Yan G, Kim ST, Fedor H, DeMarzo AM, Epstein JI, Walsh PC, Partin AW, Trock B, et al,. Individual and cumulative effect of prostate cancer risk-associated variants on clinicopathologic variables in 5,895 prostate cancer patients. Prostate 2009; 69: 1195-205.
41. Schaid DJ, McDonnell SK, Zarfas KE, Cunningham JM, Hebbring S, Thibodeau SN, Eeles RA, Easton DF, Foulkes WD, Simard J, Giles GG, Hopper JL, et al,. Pooled genome linkage scan of aggressive prostate cancer: results from the International Consortium for Prostate Cancer Genetics. Hum Genet 2006; 120: 471-85. (Pubitemid 44669782)
42. Sajantila A, Salem AH, Savolainen P, Bauer K, Gierig C, Pääbo S,. Paternal and maternal linkages reveal a bottleneck in the founding of the Finnish population. Proc Natl Acad Sci USA 1996; 93: 12035-9. (Pubitemid 26347244)
43. Peltonen L, Palotie A, Lange K,. Use of population isolates for mapping complex traits. Nat Rev Genet 2000; 1: 182-90.
44. Lemmelä S, Forsman E, Onkamo P, Nurmi H, Laivuori H, Kivelä T, Puska P, Heger M, Eriksson A, Forsius H, Järvelä I,. Association of LOXL1 gene with Finnish exfoliation syndrome patients. J Hum Genet 2009; 54: 289-97.